BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3108458)

  • 1. Thyrotropin-releasing hormone (TRH) in murine motor neuron disease (the wobbler mouse).
    Kozachuk WE; Mitsumoto H; Salanga VD; Beck GJ; Wilber JF
    J Neurol Sci; 1987 May; 78(3):253-60. PubMed ID: 3108458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone (TRH) neurons sprout in cervical spinal cord of Wobbler mouse.
    Shi J; Vacca-Galloway LL
    Brain Res; 1993 Oct; 626(1-2):83-9. PubMed ID: 8281455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in the levels of thyrotropin releasing hormone, substance P and enkephalins in the spinal cord, brainstem, hypothalamus and midbrain of the Wobbler mouse at different stages of the motoneuron disease.
    Yung KK; Tang F; Fielding R; Du YH; Vacca-Galloway LL
    Neuroscience; 1992 Sep; 50(1):209-22. PubMed ID: 1383870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JTP-2942, a novel thyrotropin-releasing hormone analogue, protects against spinal motor neuron degeneration in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    Neurosci Lett; 1998 Jun; 250(1):9-12. PubMed ID: 9696053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin releasing hormone but not histidyl-proline diketopiperazine is depleted from rat spinal cord following 5,7-dihydroxytryptamine treatment.
    Lechan RM; Jackson IM
    Brain Res; 1985 Feb; 326(1):152-5. PubMed ID: 3918765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid.
    Jackson IM; Adelman LS; Munsat TL; Forte S; Lechan RM
    Neurology; 1986 Sep; 36(9):1218-23. PubMed ID: 3092130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of neuropeptides in the brain and spinal cord of Wobbler mouse: a model for motoneuron disease.
    Tang F; Cheung A; Vacca-Galloway LL
    Brain Res; 1990 Jun; 518(1-2):329-33. PubMed ID: 1697212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised thyrotrophin-releasing hormone, pyroglutamylamino peptidase, and proline endopeptidase are present in the spinal cord of wobbler mice but not in human motor neurone disease.
    Court JA; McDermott JR; Gibson AM; Marshall E; Bloxham CA; Perry RH; Edwardson JA
    J Neurochem; 1987 Oct; 49(4):1084-90. PubMed ID: 2442304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRH and diseases of the motor system.
    Munsat TL; Lechan R; Taft JM; Jackson IM; Reichlin S
    Ann N Y Acad Sci; 1989; 553():388-98. PubMed ID: 2497682
    [No Abstract]   [Full Text] [Related]  

  • 10. A therapeutic trial of gangliosides and thymosin in the Wobbler mouse model of motor neuron disease.
    Lange DJ; Good PF; Bradley WG
    J Neurol Sci; 1983 Oct; 61(2):211-6. PubMed ID: 6644326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analog specificity of the thyrotropin-releasing hormone receptor in the central nervous system: possible clinical implications.
    Hawkins EF; Engel WK
    Life Sci; 1985 Feb; 36(6):601-11. PubMed ID: 2982071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.
    Ishiyama T; Okada R; Nishibe H; Mitsumoto H; Nakayama C
    Brain Res; 2004 Sep; 1019(1-2):226-36. PubMed ID: 15306257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional dissociation of histidyl--proline diketopiperazine (cyclo-(His--Pro)) and thyrotropin-releasing hormone (TRH) in the rat brain.
    Mori M; Prasad C; Wilber JF
    Brain Res; 1982 Jan; 231(2):451-3. PubMed ID: 6799149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice.
    Iwamoto K; Yoshii Y; Ikeda K
    Amyotroph Lateral Scler; 2009; 10(5-6):405-9. PubMed ID: 19922131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of immunoreactive thyrotropin-releasing hormone in spinal cord of patients with amyotrophic lateral sclerosis.
    Mitsuma T; Nogimori T; Adachi K; Mukoyama M; Ando K
    Am J Med Sci; 1984; 287(2):34-6. PubMed ID: 6424472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice.
    Dave KR; Prado R; Busto R; Raval AP; Bradley WG; Torbati D; Pérez-Pinzón MA
    Neuroscience; 2003; 120(1):113-20. PubMed ID: 12849745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of histidyl-proline diketopiperazine [cyclo (His-Pro)] and thyrotropin-releasing hormone (TRH) in the primate central nervous system.
    Mori M; Jayaraman A; Prasad C; Pegues J; Wilber JF
    Brain Res; 1982 Aug; 245(1):183-6. PubMed ID: 6811104
    [No Abstract]   [Full Text] [Related]  

  • 18. Decrease of enkephalins in cerebellum during Wobbler mouse motoneuron disease.
    Yung KK; Tang F; Vacca-Galloway LL
    Brain Res; 1992 Dec; 599(1):175-80. PubMed ID: 1283561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.
    Bigini P; Atzori C; Fumagalli E; Cagnotto A; Barbera S; Migheli A; Mennini T
    Neurosci Lett; 2007 Oct; 426(2):106-10. PubMed ID: 17890007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P neurons sprout in the cervical spinal cord of the wobbler mouse: a model for motoneuron disease.
    Vacca-Galloway LL; Steinberger CC
    J Neurosci Res; 1986; 16(4):657-70. PubMed ID: 2432278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.